Medibio Limited (ASX:MEB)

0.8¢

right-arrow Created with Sketch. 0.001 (7.14%)
MCAP $12.56M
Last trade 12.56pm 29/11/2021 20mins delayed

Latest Announcements

11/11/2021MEBMedibio Limited
1,496
MCap
11/11/2021MEBMedibio Limited
1,453
MCap
11/11/2021MEBMedibio Limited
228
MCap
29/10/2021 Price SensitivePSMEBMedibio Limited
7,044
MCap
27/10/2021MEBMedibio Limited
281
MCap
26/10/2021 Price SensitivePSMEBMedibio Limited
1,317
MCap
20/10/2021MEBMedibio Limited
1,283
MCap
11/10/2021MEBMedibio Limited
351
MCap

Company Overview

Medibio Limited is Australia-based health technology company. The Company offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. It offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.

MEB in the news

Medibio (ASX:MEB) strengthens IP protection

Medibio (MEB) shares have jumped 14.3 per cent following the award of…

Medibio (ASX:MEB) begins second development phase of mental health app

Medibio (MEB) has begun the second test phase of its mental health…

Medibio (ASX:MEB) illuminates mental health in the U.K.

Medibio (MEB) has signed its first statement of works agreement with Compass…

Medibio (ASX:MEB) to raise $3.5M via placement and SPP

Health technology company Medibio (MEB) plans to raise up to $3.5 million…

Search Previous Announcements